0001437749-21-009759.txt : 20210426 0001437749-21-009759.hdr.sgml : 20210426 20210426083258 ACCESSION NUMBER: 0001437749-21-009759 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaaban Bahige B. CENTRAL INDEX KEY: 0001736938 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21851664 MAIL ADDRESS: STREET 1: 888 OLD TECUMSAH RD. CITY: BELLE RIVER STATE: A6 ZIP: N0R 1A0 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5 1 rdgdoc.xml FORM 5 X0306 5 2017-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736938 Chaaban Bahige B. 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 1 Chief Executive Officer* Common Stock 2017-11-30 4 A 0 L 8750000 0 A 8914793 D Common Stock 2017-11-30 4 A 0 L 20000 0 A 8914793 D 8,770,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. * The Reporting Person resigned as the Chief Executive Officer of the Issuer on July 12, 2017 and served as the President of the Issuer beginning on July 12, 2017, and served as the Interim Chief Executive Officer of the Issuer from November 13, 2019 until April 18, 2021 and was appointed as the Chief Executive Officer of the Issuer on April 19, 2021. /s/ Bahige Chaaban 2021-04-26